Marinus
is a Pennsylvania-based biopharmaceutical company that develops and commercializes therapies for the treatment of epilepsy and neuropsychiatric disorders... Read moreMarinus
is a Pennsylvania-based biopharmaceutical company that develops and commercializes therapies for the treatment of epilepsy and neuropsychiatric disorders... Read more
2003
PublicAcquired by Immedica Pharma ABNASDAQMRNS
News
Sep 27, 2025
Benzinga
Marinus: MARINUS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Marinus Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Feb 17, 2025
Medthority
Marinus: Immedica Acquires Marinus Pharma
Jan 08, 2025
Global Legal Chronicle
Marinus: Immedica Pharma AB's Acquisition of Marinus Pharmaceuticals
Jan 06, 2025
centralcharts
Press Release: Marinus : MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc.
Jan 03, 2025
Benzinga
Marinus: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MoneyLion Inc. (NYSE - ML), Marinus Pharmaceuticals, Inc. (Nasdaq - MRNS), Better Choice Inc. (NYSE American - BTTR), NeueHealth, Inc. (NYSE - NEUE)
Jan 02, 2025
The Business Journals: Philadelphia
Marinus: Marinus executives in line for bonuses after acquisition deal triggers retention payouts
Dec 31, 2024
Medthority
Marinus: Marinus regains EU rights for ganaxolone
Nov 14, 2024
BioSpace
Marinus: Marinus Pharmaceuticals Lays Off 45% of Employees
Nov 13, 2024
Owler
Marinus Pharmaceuticals, Inc.: Marinus's revenue changed from $30.26M in Jun 2024 to $31.47M in Sep 2024
Oct 25, 2024
Clinical Trials Arena
Marinus: Marinus' clinical trial of ganaxolone fails to meet primary endpoint
Marinus Competitors
1
2
3
4
5
6
7
8
9
10